One Step Benzodiazepine Test

Rapid BZD Test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of benzodiazepines and their metabolites in human urine specimens. This assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/ mass spectrometry (GC/MS) has been established as the preferred confirmatory method by the Substance Abuse Mental Health Services Administration (SAMHSA). Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

Release form

Quantity

Price

{{ item.price }} UAH
Total {{ Vue.prototype.totalP }}
UAH

Product Description

Producer:

Xiamen Boson Biotech Co., Ltd

Country of production:

China

Article:

1L03S3Т

Brief description:

Rapid BZD Test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of benzodiazepines and their metabolites in human urine specimens. This assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/ mass spectrometry (GC/MS) has been established as the preferred confirmatory method by the Substance Abuse Mental Health Services Administration (SAMHSA). Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

Appointment:

Qualitative determination of benzodiazepines and their metabolites in human urine specimens.

Materials provided:

1. One Step BZD Test. The amount of each coated antigen and/or antibody on the strip is less than 1.0 mg for antigen conjugate and is less than 1.0 mg for goat anti-rabbit IgG antibody. Test zone: contains drug bovine protein antigen conjugates Control zone: contains Goat anti-rabbit IgG antibody Conjugate pad: contains anti-drug antibody.
2. Instruction for use.

Materials required but not provided:

1. Urine collection container.
2. Timer or clock.

Accuracy

The accuracy of the benzodiazepine test was evaluated in comparison to GC/MS method and commercial kits at a cut-off of 300 ng/ml of oxazepam. Three hundred and forty four (344) urine specimens which composed of one hundred eleven (111) benzodiazepine positive samples and two hundred thirty three (233) negative samples were evaluated in this study. The results are summarized as below: Positive % agreement: 98, Negative % agreement: 100

Sensitivity

The cut-off concentration (sensitivity level) of the Rapid BZD Test is determined to be: oxazepam 300 ng/ml.

Precision

The precision of Rapid BZD Test was determined by conducting the test with spiked controls and interpreted the results by three individuals to verify the random error of visual interpretation. The results of 40 samples each of 50% above and 50% below cut-off specimens are 100% agreed by three observers. The test results were found to have no significant differences between these three observers.

Sample type

urine

Delivery

Implemented by Nova Poshta. If the order is above 1500 UAH, the sender pays the shipping cost

Instructions for use (PDF) Declaration of Conformity (PDF)